Part 1: When to test
Part 1: When to test
Part 2: Who to test
The role of testing in prostate cancer treatment
Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies
Clinically sufficient vitamin D levels at breast cancer diagnosis and survival outcomes
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC
LEAP-004: Lenvatinib + pembrolizumab for patients with advanced melanoma and confirmed progression on a PD-1 or PD-L1 inhibitor
OncoAlert and ecancer ASCO roundup - Day 3
OncoAlert and ecancer ASCO roundup - Day 2
OncoAlert and ecancer ASCO roundup - Day 1
Incidence and trends of HPV-related cancers in the United States
European Cancer Organisation: Time To Act